Loading company…
Tokyo-based Splink provides cloud-based brain health tools, including the CQ test and AI analysis of MRI images.
Splink, Inc. was founded in 2017 in Tokyo, Japan, and offers cloud-based brain healthcare products for assessing and supporting cognitive function. Its CQ test is a self-assessment cognitive measurement tool, and its Braineer program analyzes brain volume reduction from MRI data as a medical device program. Services are sold to healthcare institutions and consumers, mainly on a subscription basis. The company completed a Series B round in November 2021, raising JPY 1.03 billion from investors including Hakuhodo DY Holdings and Mitsubishi UFJ Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in